Blog

Power Metal Resources PLC (LSE:POW) has made a strategic investment in Minestarters, a blockchain-based DeFi platform designed to revolutionize mining finance by offering tokenized investment opportunities in early-stage mining projects. This initiative positions Power Metal as a pioneer in the emerging real-world asset tokenization space, potentially creating new value streams for shareholders.

Minestarters will deliver a compliant and transparent platform for both institutional and retail investors, helping to bridge the funding gap in early-stage mining ventures and establishing a new hybrid DeFi asset class.

Power Metal Resources’ outlook is supported by strong revenue growth and a robust balance sheet, though operational challenges and negative cash flows are factors to monitor. The stock’s undervaluation presents a potential opportunity, while technical indicators signal caution amid bearish trends.

About Power Metal Resources PLC

Power Metal Resources PLC is a London-listed natural resources exploration company and project incubator with a global portfolio. The company specializes in creating value through project incubation and crystallization, with a particular focus on the mining sector.

This content is for informational purposes only and does not constitute financial, investment, or other professional advice. It should not be considered a recommendation to buy or sell any securities or financial instruments. All investments involve risk, including the potential loss of principal. Past performance is not indicative of future results. You should conduct your own research and consult with a qualified financial advisor before making any investment decisions.

Metals Exploration PLC (LSE:MTL) posted record free cash flow and strong first-half 2025 earnings, supported by operations at the Runruno project and favorable gold market conditions. The company’s acquisition of Condor Gold and the launch of the La India project in Nicaragua represent key milestones in its expansion strategy, with plans for extensive drilling and development to grow gold resources and production capacity. Community engagement and safety remain central, with ongoing initiatives in both the Philippines and Nicaragua.

The company’s outlook is underpinned by robust financial performance, including significant revenue growth and strong cash flow generation. However, technical indicators suggest a bearish trend, and while the valuation is fair, the absence of a dividend yield is a consideration. Limited earnings call data and recent corporate events mean these factors have minimal impact on the current assessment.

About Metals Exploration PLC

Metals Exploration PLC is a gold production, exploration, and development company with assets in the Philippines and Nicaragua. Its strategy focuses on growth through strategic acquisitions and development projects, aiming to establish a multi-project portfolio.

This content is for informational purposes only and does not constitute financial, investment, or other professional advice. It should not be considered a recommendation to buy or sell any securities or financial instruments. All investments involve risk, including the potential loss of principal. Past performance is not indicative of future results. You should conduct your own research and consult with a qualified financial advisor before making any investment decisions.

Iofina plc (LSE:IOF) achieved a record monthly iodine production of 74.3 metric tons in August 2025, driven by operational efficiency and the commissioning of its new plant, IO#11. The company also reported a $1.8 million increase in cash reserves, supported by Employee Retention Tax Credit refunds received for retaining staff during the COVID-19 pandemic.

These milestones highlight Iofina’s focus on growth and operational excellence, with plans to expand into new areas and further increase iodine production in the future.

About Iofina plc

Iofina plc is a vertically integrated producer of iodine and specialty chemical products. It ranks as North America’s second-largest iodine producer and operates through Iofina Resources and Iofina Chemical. Iofina Resources develops and manages iodine extraction plants using proprietary technology, while Iofina Chemical manufactures high-quality halogen specialty chemicals.

This content is for informational purposes only and does not constitute financial, investment, or other professional advice. It should not be considered a recommendation to buy or sell any securities or financial instruments. All investments involve risk, including the potential loss of principal. Past performance is not indicative of future results. You should conduct your own research and consult with a qualified financial advisor before making any investment decisions.

Vertu Motors (LSE:VTU) reported steady results for the five months ending July 2025, with used car volumes and margins holding firm despite supply constraints and subdued consumer confidence. Growth in the aftersales segment has been strong, and the company has maintained tight cost control even amid inflationary pressures.

Challenges persist in the new car market due to the Zero Emission Vehicle mandate and broader consumer trends. However, government incentives for electric vehicles are expected to support demand. Vertu Motors is also expanding its presence with new BYD sales outlets and continues its share buyback program, reinforcing shareholder value. Additionally, the company is engaged in discussions with the Financial Conduct Authority regarding a proposed motor finance redress scheme following a Supreme Court ruling.

The company’s outlook is underpinned by a solid financial base and attractive valuation, including a low P/E ratio and healthy dividend yield. Share buybacks further enhance value, though technical indicators are mixed, showing short-term bearish signals offset by longer-term support. Limited recent earnings call data leaves some uncertainty regarding management’s strategic outlook.

About Vertu Motors

Vertu Motors is a leading UK automotive retailer with 195 sales and aftersales locations. The company specializes in new and used car sales and high-margin aftersales services, including vehicle repair and maintenance.

This content is for informational purposes only and does not constitute financial, investment, or other professional advice. It should not be considered a recommendation to buy or sell any securities or financial instruments. All investments involve risk, including the potential loss of principal. Past performance is not indicative of future results. You should conduct your own research and consult with a qualified financial advisor before making any investment decisions.

Tern plc (LSE:TERN) reported a marked improvement in its financial performance for the first half of 2025, with losses reduced by 64% compared to H1 2024, supported by a 7% reduction in administrative expenses. The company also made a strategic investment in Sure Ventures plc to diversify its holdings and capture potential synergies, while raising additional capital through successful share placements to support its investment strategy.

Despite ongoing macroeconomic pressures affecting its portfolio companies, Tern continues to prioritize disciplined cash management and long-term value creation for shareholders.

About Tern plc

Tern plc focuses on generating value from Internet of Things (IoT) technology businesses. Operating within the broader technology sector, the company invests in areas such as IoT, Artificial Intelligence (AI), Augmented Reality (AR), and Virtual Reality (VR). Tern targets high-growth technology firms and provides support to early-stage, disruptive IoT portfolio companies.

This content is for informational purposes only and does not constitute financial, investment, or other professional advice. It should not be considered a recommendation to buy or sell any securities or financial instruments. All investments involve risk, including the potential loss of principal. Past performance is not indicative of future results. You should conduct your own research and consult with a qualified financial advisor before making any investment decisions.

Fusion Antibodies plc (LSE:FAB) reported significant revenue growth for the year ending March 2025, with sales rising to £1.97 million from £1.14 million the previous year. The company highlighted its strategic advancements in the diagnostics market, reducing dependence on the more volatile biotech sector, alongside securing several major contract wins. A successful £1.17 million fundraising round and collaboration with the U.S. National Cancer Institute have strengthened its flagship OptiMAL® program, positioning the company for continued expansion.

Despite broader economic uncertainty, Fusion Antibodies sees opportunities arising from funding pressures in the biotechnology sector, as companies increasingly outsource development to manage costs. However, the company still faces financial challenges, including prior losses and declining revenues. Technical indicators suggest bearish momentum, and valuation metrics reflect ongoing unprofitability. Nonetheless, recent fundraising and strategic collaborations provide cautious optimism for the future.

About Fusion Antibodies plc

Based in Belfast, Fusion Antibodies plc is a contract research organization specializing in pre-clinical antibody discovery, engineering, and supply for therapeutic and diagnostic applications. Its services include antibody generation, development, production, characterization, and optimization, helping pharmaceutical and diagnostic companies accelerate the development of innovative products. The company serves an international client base, including major pharmaceutical firms.

This content is for informational purposes only and does not constitute financial, investment, or other professional advice. It should not be considered a recommendation to buy or sell any securities or financial instruments. All investments involve risk, including the potential loss of principal. Past performance is not indicative of future results. You should conduct your own research and consult with a qualified financial advisor before making any investment decisions.

Defence Holdings PLC (LSE:ALRT) has revealed its inaugural AI product at DSEI 2025, developed in collaboration with the UK Ministry of Defence and a leading technology partner. The launch, part of a strategic alliance with Whitespace Global Limited, represents a major milestone for Defence Holdings, strengthening its position in the defence sector by delivering sovereign-grade scalability, resilience, and security in its technology solutions.

About Defence Holdings PLC

Defence Holdings PLC is the UK’s first publicly listed, software-focused defence company, dedicated to providing sovereign digital capabilities across national security, resilience, and defence readiness.

This content is for informational purposes only and does not constitute financial, investment, or other professional advice. It should not be considered a recommendation to buy or sell any securities or financial instruments. All investments involve risk, including the potential loss of principal. Past performance is not indicative of future results. You should conduct your own research and consult with a qualified financial advisor before making any investment decisions.

Concurrent Technologies Plc (LSE:CNC) has secured its largest UK defence deal to date, valued at £4 million, with a leading UK defence prime contractor. The agreement covers the supply of rugged single-board computers compliant with the VME standard, tailored to specific customer requirements, with deliveries scheduled through 2028 and options to extend into the 2030s.

The contract represents a strategic partnership emphasizing obsolescence management and technology upgrades, supporting European border security initiatives. CEO Miles Adcock noted that this deal strengthens the company’s presence in the UK defence market and reinforces its commitment to the VME standard.

Concurrent Technologies’ solid financial performance is underpinned by strong revenue growth, profitability, and stability. However, technical indicators suggest limited upward momentum, and a high P/E ratio raises concerns about potential overvaluation, moderating the outlook.

About Concurrent Technologies

Concurrent Technologies Plc designs and manufactures high-performance embedded plug-in cards and systems for a variety of applications in telecommunications, defence, security, telemetry, scientific research, and aerospace, including extreme environments. Its products feature Intel® processors—including the latest embedded Intel® Core™, Xeon®, and Atom™ processors—and comply with industry specifications while supporting major embedded operating systems. The company’s solutions are distributed globally.

This content is for informational purposes only and does not constitute financial, investment, or other professional advice. It should not be considered a recommendation to buy or sell any securities or financial instruments. All investments involve risk, including the potential loss of principal. Past performance is not indicative of future results. You should conduct your own research and consult with a qualified financial advisor before making any investment decisions.

Shield Therapeutics (LSE:STX) has announced that the U.S. FDA has accepted ACCRUFeR®/FeRACCRU® for Priority Review, aiming to expand its use to adolescents with iron deficiency anemia. Approval is expected in 2026. This follows successful Phase 3 trials and could broaden the treatment’s reach, offering a convenient oral option for adolescents and potentially adults who struggle to swallow capsules.

The company’s outlook is shaped by strong technical performance and market momentum. However, financial challenges, including negative profitability and cash flow constraints, weigh on its overall assessment. Additional concerns stem from valuation metrics, with a negative P/E ratio and no dividend yield affecting investor appeal.

About Shield Therapeutics

Shield Therapeutics plc is a specialty pharmaceutical company at the commercial stage, focused on treating iron deficiency, with or without anemia. Its flagship product, ACCRUFeR®/FeRACCRU® (ferric maltol), is available in the U.S. through a partnership with Viatris and licensed to pharmaceutical companies across Europe, China, and Japan.

This content is for informational purposes only and does not constitute financial, investment, or other professional advice. It should not be considered a recommendation to buy or sell any securities or financial instruments. All investments involve risk, including the potential loss of principal. Past performance is not indicative of future results. You should conduct your own research and consult with a qualified financial advisor before making any investment decisions.

Currys plc (LSE:CURY) has delivered a strong start to the financial year, posting a 3% rise in like-for-like sales in the UK & Ireland and a 2% increase in its Nordic operations. Alongside the growth, the company unveiled a £50 million share buyback program as it continues to prioritize profitable sales and disciplined cost management.

Management remains confident in the group’s growth prospects, with a particular focus on expanding new categories and services. A key milestone includes reaching a target of at least 2.5 million iD Mobile subscribers by the end of the year. The company’s emphasis on recurring revenue streams and prudent capital deployment is expected to support stronger returns and profitability over time.

Currys’ outlook reflects stable financial performance and a favorable valuation profile. Although technical indicators point to weak momentum, strong cash flow and a low P/E ratio underpin the investment case. Profitability challenges persist, but the stock’s resilient base suggests potential for recovery.

About Currys plc

Currys plc is a leading omnichannel retailer of consumer technology, serving customers through 708 stores across six countries as well as online platforms. In the UK & Ireland, it operates under the Currys brand and runs its own mobile network, iD Mobile. In the Nordics, the group trades as Elkjøp. Currys employs more than 24,000 people and is a market leader in all the regions where it operates.

This content is for informational purposes only and does not constitute financial, investment, or other professional advice. It should not be considered a recommendation to buy or sell any securities or financial instruments. All investments involve risk, including the potential loss of principal. Past performance is not indicative of future results. You should conduct your own research and consult with a qualified financial advisor before making any investment decisions.